Historical salary details - Dr. Michael Harvey Davidson, M.D., Independent Director, Silence Therapeutics Plc - ADR
Dr. Michael Harvey Davidson, M.D. is the Independent Director of Silence Therapeutics Plc - ADR.
Dr. Michael Harvey Davidson, M.D.
Independent Director
-
Gross Remuneration
-
Current Company
Silence Therapeutics Plc - ADR
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2025 | Silence Therapeutics Plc - ADR | Independent Director | - | - |
| 2024 | Tenax Therapeutics Inc | Independent Director | 575.5 K | 900.9 % |
| 2024 | BioAge Labs Inc. | Independent Director | 492.4 K | - |
| 2024 | Silence Therapeutics Plc - ADR | Independent Director | 208.1 K | - |
| 2024 | NewAmsterdam Pharma Company NV | Chief Executive Officer and Director | - | - |
| 2023 | Tenax Therapeutics Inc | Independent Director | 57.5 K | -4.3 % |
| 2023 | NewAmsterdam Pharma Company NV | Chief Executive Officer and Director | - | - |
| 2022 | Lisata Therapeutics Inc | Independent Director | 97.8 K | -13.8 % |
| 2022 | Tenax Therapeutics Inc | Independent Director | 60.1 K | 11.3 % |
| 2022 | Lisata Therapeutics Inc | Independent Director | - | - |
| 2022 | Silence Therapeutics Plc - ADR | Independent Director | - | - |
| 2022 | NewAmsterdam Pharma Company NV - Warrants (15/11/2027) | Chief Executive Officer and Director | - | - |
| 2021 | Lisata Therapeutics Inc | Independent Director | 113.5 K | -20.1 % |
| 2021 | Silence Therapeutics Plc - ADR | Independent Director | 54 K | - |
| 2021 | Tenax Therapeutics Inc | Independent Director | 54.0 K | - |
| 2021 | NewAmsterdam Pharma Company NV | Chief Executive Officer and Director | - | - |
| 2020 | Lisata Therapeutics Inc | Independent Director | 142.0 K | - |
| 2020 | Silence Therapeutics Plc - ADR | Independent Director | - | - |
| 2020 | Tenax Therapeutics Inc | Independent Director | - | - |